Pharma’s Role in Healthcare Reform: 5 Actionable Steps

In my last post, I asked a simple but searing question: Where the hell is pharma while the U.S. healthcare system is being decimated? The answer, infuriatingly, is: nowhere to be found. But let’s pivot—because if pharma wants to step up, there are clear, actionable steps it could take to lead the charge in fixing a healthcare system that has become a playground for profiteers.

1. Expose the Insurance Scam That Denies Treatment

Every day, patients are being denied critical treatments and diagnostics by insurers, the very steps required before a prescription drug can even be used. This isn’t just morally outrageous—it directly undercuts pharma’s ability to serve patients.

Pharma should:

  • Fund hard-hitting public awareness campaigns exposing prior authorization abuse and step therapy delays.
  • Partner with doctors and hospitals to collect real-world data on insurer denials and their lethal consequences.
  • Use its advertising might to tell the real patient stories—not scripted testimonials, but the brutal truth about a system that denies, delays, and dehumanizes.

2. Take a Stand Against Private Equity in Care Delivery

Private equity is swallowing up everything from hospice care to oncology to OB-GYN clinics. The result? Slashed staffing, upcoding, billing fraud, and patients treated as revenue streams instead of human beings.

Pharma should:

  • Publicly condemn the corporate raiding of clinical care.
  • Refuse to contract with PE-backed care conglomerates that prioritize investor returns over patient outcomes.
  • Push for legislation that limits PE involvement in essential healthcare services.

3. Lobby for Healthcare Access, Not Just Patent Protection

Pharma has some of the most powerful lobbyists in Washington. However, far too often, they’re used to defend exclusivity extensions and price protections rather than patient rights.

Pharma should:

  • Redirect lobbying dollars to support legislation that ensures access to diagnostics, follow-up care, and specialist referrals—because what good is a drug if the system prevents its use?
  • Fight for limits on junk insurance plans that trick patients into thinking they’re covered until it’s too late.
  • Demand automatic Medicaid and Medicare coverage for new, life-saving drugs for conditions with unmet needs.

4. Call Out the Real Drivers of High Healthcare Costs

Pharma takes all the heat for high drug prices, but the reality is that middlemen, such as Pharmacy Benefit Managers (PBMs) and insurers, are pocketing massive rebates, leaving patients with outrageous out-of-pocket costs.

Pharma should:

  • Use its voice to push for PBM reform and full rebate transparency.
  • End backroom deals that benefit payers but hurt patients.
  • Partner with employer coalitions and state governments to demand value-based pricing models that reward outcomes, not complexity.

5. Back Patients With Action, Not Platitudes

Pharma loves to say “we care about patients.” If that’s true, it’s time to act like it.

Pharma should:

  • Fund independent patient advocacy groups—not industry-fronted nonprofits—that actually fight for system-wide reform.
  • Create emergency access funds for patients denied care due to insurer delays.
  • Help doctors navigate access barriers for critical treatments with dedicated support teams that advocate with payers, not just sales reps who drop off brochures.

Pharma Has the Power—Now It Needs the Will

Let’s be blunt: if pharma united around fixing healthcare—not for PR, not for profits, but for people—it could be the loudest, most influential voice in the country. The question isn’t whether pharma can make a difference. It’s whether it cares enough to try.

Because if it doesn’t, patients will remember. Doctors will remember. And the next time the industry claims to be part of the solution, we’ll all know better.

About Richard Meyer

I’m Richard Meyer — a 25 year healthcare marketing strategist and writer focused on the intersection of direct-to-consumer marketing, healthcare economics, and human behavior.I started Work of DTC Marketing because too much of the conversation around pharma and healthcare marketing is either overly promotional, overly technical, or completely disconnected from how the system actually works.Here, I write about what DTC really does, how incentives drive behavior inside healthcare organizations, why patients are often treated like revenue streams instead of people, and why “best practices” are frequently just recycled assumptions.My background spans digital marketing, public relations, and healthcare strategy, and my approach is pragmatic, skeptical of hype, and grounded in data and lived experience. I’m less interested in what sounds good in a deck and more interested in what actually changes outcomes — for companies, doctors, and especially patients.

View all posts by Richard Meyer →

Leave a Reply